Detalles de la búsqueda
1.
Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease.
Mov Disord
; 37(10): 2045-2056, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35959805
2.
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
NPJ Parkinsons Dis
; 9(1): 114, 2023 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37460603
3.
Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants.
Hum Vaccin Immunother
; 16(6): 1327-1337, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31951765
4.
Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
NPJ Parkinsons Dis
; 10(1): 60, 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486014
Resultados
1 -
4
de 4
1
Próxima >
>>